| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 292.800 | 281.431 | 275.902 | 237.836 | 170.832 | 213.407 | 185.201 | 202.177 | 195.388 | 156.240 |
| Total Income - EUR | 292.925 | 281.420 | 275.904 | 237.879 | 171.242 | 213.510 | 185.310 | 212.498 | 195.456 | 156.778 |
| Total Expenses - EUR | 298.652 | 290.061 | 285.947 | 245.772 | 181.417 | 225.225 | 203.996 | 233.427 | 239.037 | 204.069 |
| Gross Profit/Loss - EUR | -5.726 | -8.641 | -10.044 | -7.892 | -10.176 | -11.715 | -18.686 | -20.928 | -43.581 | -47.291 |
| Net Profit/Loss - EUR | -5.726 | -8.641 | -10.044 | -8.390 | -10.176 | -11.715 | -18.686 | -20.928 | -43.581 | -47.291 |
| Employees | 6 | 5 | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Covalexion Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.791 | 2.392 | 16.067 | 12.018 | 8.084 | 4.356 | 1.216 | 85.643 | 62.195 | 39.482 |
| Current Assets | 22.497 | 23.915 | 39.208 | 58.986 | 74.639 | 74.413 | 60.867 | 52.567 | 34.745 | 30.184 |
| Inventories | 19.040 | 22.723 | 37.126 | 54.395 | 69.251 | 67.273 | 52.457 | 47.822 | 28.339 | 25.881 |
| Receivables | 2.210 | 1.002 | 1.811 | 4.462 | 4.981 | 5.749 | 3.548 | 2.713 | 1.986 | 1.631 |
| Cash | 1.247 | 189 | 271 | 129 | 407 | 1.390 | 4.863 | 2.032 | 4.420 | 2.671 |
| Shareholders Funds | -2.510 | -11.125 | -10.079 | -18.283 | -28.105 | -39.288 | -57.103 | -78.208 | -121.552 | -168.163 |
| Social Capital | 45 | 45 | 10.945 | 10.745 | 10.537 | 10.337 | 10.108 | 10.139 | 10.108 | 10.052 |
| Debts | 27.798 | 37.432 | 65.354 | 89.287 | 110.829 | 118.056 | 119.186 | 216.418 | 218.492 | 237.829 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Covalexion Srl